Evidence map›Paper›PMID 41783789›Full record

ArticleMolecular therapy. Nucleic acids2026

Rabies lyssavirus phosphoprotein possesses RNA duplex-unwinding activities.

Jingfang Mu, Caiqian Wang, Ting Shu, Xiaobei Xiong, Yujie Ren, Rui Gong, Ling Zhao, Xi Zhou

Abstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jingfang MuState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
Caiqian WangNational Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
Ting ShuState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
Xiaobei XiongState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
Yujie RenState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
Rui GongState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.
Ling ZhaoNational Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei 430070, China.
Xi ZhouState Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei 430071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rabies lyssavirus (RABV) is a prototypical neurotropic virus that belongs to the Rhabdoviridae family and causes one of the most lethal zoonotic diseases. For RNA viruses, RNA-unwinding proteins such as helicases and RNA chaperones are crucial for the replication and/or correct folding of viral RNAs. Although numerous RNA viruses have been found to encode their RNA-unwinding proteins, no RNA-unwinding activity has been identified in the family Rhabdoviridae. Herein, we uncovered that RABV phosphoprotein (RABV-P) possesses both a nucleoside triphosphate (NTP)-dependent helicase-like RNA duplex-unwinding activity and an NTP-independent duplex-unwinding and annealing activity. The C-terminal domain of RABV-P is required for its RNA-unwinding activities, whereas the NTP-dependent helicase-like unwinding activity also relies on its central oligomerization domain (COD). Furthermore, we designed two peptides (named P90 and P110) to target the COD and revealed that these peptides effectively inhibited RABV replication in cells. Overall, the study provides the first demonstration of the RNA helicase-like and NTP-independent RNA-unwinding/annealing activities associated with a rhabdovirus-encoded protein. This study highlights the functional significance of P in the RABV life cycle and probably other rhabdoviruses, and targeting RABV-P represents a promising strategy for developing novel antivirals against this lethal pathogen.

Indexed as

antiviral targetMT: Oligonucleotides: Therapies and Applicationsphosphoprotein (P) of RABVrabies lyssavirusRABVRNA chaperone activityRNA-unwinding activity

Identifiers

PMID41783789
PMCPMC12955105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.